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1. INTRODUCTION {#mgg3821-sec-0005}
===============

Hepatitis C virus (HCV) infection is one of causative reasons of chronic hepatitis and serious liver diseases worldwide. About 180 million persons are infected by HCV in the world (Micallef, Kaldor, & Dore, [2006](#mgg3821-bib-0021){ref-type="ref"}). Although direct‐acting antivirals (DAAs) greatly increase curative ratio of HCV infected persons, wide prevalence, high mutant rate, presence of cirrhosis, and expansive cost bring to difficulties for HCV therapy (Bagaglio, Uberti‐Foppa, & Morsica, [2017](#mgg3821-bib-0004){ref-type="ref"}; Hayes & Chayama, [2017](#mgg3821-bib-0015){ref-type="ref"}). Thus, it is important to further understand the pathogenic mechanisms of HCV infection and disease progression. Host genetic susceptibility is associated with HCV infection, viral clearance, and therapy effect, and most of these susceptibility genes belong to interleukin family (Falleti et al., [2010](#mgg3821-bib-0011){ref-type="ref"}; Kao et al., [2017](#mgg3821-bib-0017){ref-type="ref"}; Sghaier et al., [2017](#mgg3821-bib-0026){ref-type="ref"}), which is important cytokine in immunoreaction.

Genetic polymorphisms in the interleukin 28B gene (*IL28B*, OMIM 607402) are widely identified to associate with viral clearance and therapy effect in many populations (Ge et al., [2009](#mgg3821-bib-0012){ref-type="ref"}; Thomas et al., [2009](#mgg3821-bib-0035){ref-type="ref"}). At the same time, chronic HCV infection could decrease the IL28B serum level (Alborzi et al., [2017](#mgg3821-bib-0002){ref-type="ref"}). Similarly, the interleukin 6 gene (*IL6*) plays an important role in human immunologic antagonism, so the genetic variations in the *IL6* gene are commonly studied in HCV infected persons (Cussigh et al., [2011](#mgg3821-bib-0008){ref-type="ref"}). Single nucleotide polymorphism (SNP) of the *IL6* gene is associated with HCV viral clearance, and the serum IL6 level shows higher in HCV infected persons (Tarrago et al., [2014](#mgg3821-bib-0034){ref-type="ref"}). All above, the genetic polymorphisms of the interleukin genes could influence the infection, pathopoiesis, and treatment effect of HCV patients. Until now, no study was performed to reveal the genetic role of a signaling pathway in HCV infected population.

The proteins in signal transducer and activator of transcription (STAT) family are identified to be critical factors in cytokine signaling pathway. Mutations in the *STAT3* gene could lead to many kinds of cancers (Shahmarvand, Nagy, Shahryari, & Ohgami, [2018](#mgg3821-bib-0027){ref-type="ref"}). STAT3 protein together with IL6, HNF4A, HNF1A, and three microRNAs constructed a feedback loop, which regulates oncogenesis of hepatocellular carcinoma (HCC) (Hatziapostolou et al., [2011](#mgg3821-bib-0014){ref-type="ref"}). HNF4A is essential for liver function and regulates the expression level of HNF1A, which controls several genes of hepatic development. IFN signaling and IL6 signaling pathways could activate STAT3 protein when HCV core protein highly expressed (Tacke, Tosello‐Trampont, Nguyen, Mullins, & Hahn, [2011](#mgg3821-bib-0033){ref-type="ref"}). In addition, the *ABCC2* gene encodes a member in the ATP‐binding cassette (ABC) transporters superfamily, which expression level decreased in HCC tissues induced by HCV (Billington et al., [2018](#mgg3821-bib-0005){ref-type="ref"}). Interestingly, the *ABCC2* gene locates in downstream of the HNF1A and HNF4A genes (Qadri, Iwahashi, Kullak‐Ublick, & Simon, [2006](#mgg3821-bib-0025){ref-type="ref"}). Thus, the IL6/HNF4A/HNF1A/STAT3/ABCC2 signaling pathway might participate in HCV infection, pathogenic process, and treatment effect, but whether genetic variations of these genes could influence HCV infection remains unclear.

In this study, we investigated whether there was relationship between genetic polymorphisms of genes in STAT3 signaling pathway and HCV infection in Yunnan population, and validated the function of STAT3 pathway in HCV‐infected cells.

2. MATERIALS AND METHODS {#mgg3821-sec-0006}
========================

2.1. Ethical complicance {#mgg3821-sec-0007}
------------------------

Written informed consents conforming to the tenets of the Declaration of Helsinki were obtained from each participant prior to the study. The institutional review board of Kunming University of Science and Technology approved this study (Approval No. 2014SK027).

2.2. Subjects {#mgg3821-sec-0008}
-------------

394 chronic HCV‐infected subjects and 395 general controls were recruited in First People\'s hospital of Yunnan Province. The patients were diagnosed as chronic HCV infected persons by the symptoms and liver function test. All HCV‐infected patients were identified to be anti‐HCV positive by HCV ELISA Kit (ORTHO, USA), and all patients were without any medical treatment when we collected the samples. None individual carried serious liver disease, and all individuals were without Hepatitis B virus (HBV) infection detected by using Quantitative CLIA Kit (Autobio, China)and/or Human Immunodeficiency virus (HIV) infection detected by using Anti‐HIV ELISA Kit (WANTAI, China). The persons, who were anti‐HCV positive, HBV DNA negative, and anti‐HIV negative, were classified to HCV‐infected patients group. Moreover, controls were anti‐HCV, HBV DNA, and anti‐HIV negative. The basic information and biochemical characteristics \[including Glutamyl transpeptidase (GGT) glutamic‐pyruvic transaminase (GPT or ALT), aspartate amino‐transferase (GOT or AST), albumin (ALB), total bilirubin (TBIL), and high‐density lipoprotein cholesterol (HDL‐C)\] of all subjects were collected for further analysis. 5 ml whole blood were collected from each subject for single nucleotide polymorphism (SNP) analysis.

2.3. Genomic DNA extraction and genotyping {#mgg3821-sec-0009}
------------------------------------------

Genomic DNA was extracted from whole blood by using TIANamp Blood DNA Kit (TIANGEN, China). Twenty‐five SNPs (rs1524107, rs2069837, rs2069840, rs2069852, rs4845617, rs12090237, rs4075015, rs7553796, rs4845374, rs4509570, rs1053023, rs1053004, rs4796793, rs3787349, rs3212172, rs1800963, rs6073435, rs1169309, rs11065390, rs41279096, rs1885301, rs7910642, rs2804402, rs717620, and rs2273697) of six genes (*IL6*, *IL6R*, *HNF1A*, *HNF4A*, *STAT3*, and *ABCC2*) in STAT3 signaling pathway were selected according to the criteria that the minor allele frequency of SNP is more than 2% in dbSNP ([www.ncbi.nlm.nih.gov/SNP](http://www.ncbi.nlm.nih.gov/SNP)). These SNPs were tagSNPs ([ftp.ncbi.nlm.nih.gov/hapmap/](ftp.ncbi.nlm.nih.gov/hapmap/), CHB + JPT) or SNPs in functional region (coding region, 5′‐untranslated region, and 3′‐untranslated region). Then, each SNP was genotyped by using Ligase Detection Reaction (LDR) or SnapShot assay (the primers were listed in Tables [S1](#mgg3821-sup-0002){ref-type="supplementary-material"} and [S2](#mgg3821-sup-0003){ref-type="supplementary-material"}). The genotyping results of random 10% samples with each SNP were verified by sequencing. The linkage disequilibrium (LD) maps for SNPs in each gene were calculated by using SHEsis (analysis.bio‐x.cn/myAnalysis.php) (Shi & He, [2005](#mgg3821-bib-0028){ref-type="ref"}) and listed in Figure [S1](#mgg3821-sup-0001){ref-type="supplementary-material"}.

2.4. HCV RNA extraction, genotyping and quantification {#mgg3821-sec-0010}
------------------------------------------------------

HCV RNA was abstracted from serum of each HCV‐infected individual by using TIANamp Virus RNA Kit (TIANGEN, China). Two pairs of primers (HCV‐1F/HCV‐1R: 5′‐ GGCGACACTCCACCATGAATCACT‐3′/5′‐ GTATGTACCCCATGAGGTCGGC‐3′; HCV‐2F/HCV‐2R: 5′‐ AATCACTCCCCTGTGAGGAACTACTGT‐3′/5′‐ AGGGTATCGATGACCTTACCCA‐3′) were designed to amplify NS5B gene of HCV by using nest PCR (Lu et al., [2005](#mgg3821-bib-0020){ref-type="ref"}; Zhang et al., [2014](#mgg3821-bib-0037){ref-type="ref"}). The PCR condition was as following: one cycle of 94°C for 5 min, 30 cycles of 94°C for 30 s, 50°C for 30 s, and 72°C for 50 s, and one extension cycle of 72°C for 5 min. The NS5B fragment was sequenced to genotype HCV. Taqman probe assay was used to detect HCV viral load by primers HCV‐3F/HCV‐3R (5′‐TGCTCATGATGCACGGTCTAC‐3′/5′‐TGCGGAACCGGTGAGTACAT‐3′), probe (FAM‐CACCCTATCAGGCAGTACCACAAGGCC‐TAMRA), and ABI 7,500 Fast Real‐Time PCR system (Applied Biosystems, USA). The lowest limit of detection was 1,000 copies/mL. HCV RNA was further transformed as log10‐transformation, i.e., the lowest limit of detection was 3 log10 copies/mL.

2.5. Plasmid construction {#mgg3821-sec-0011}
-------------------------

Total RNA was extracted from Huh7.5.1 cells by using TRIzol Reagent (Invitrogen, USA). 1 μg RNA was reversely transcripted to complementary DNA (cDNA) by using PrismScript^TM^ RT reagent Kit with gDNA Eraser (Takara, Japan). The *IL6* gene (GenBank No.: NM_000600) was amplified by using primers IL6‐F and IL6‐R: CCG*CTCGAG*ATGAACTCCTTCTCCACA/GGG*AAGCTT*CTA**CTTGTCATCGTCGTCCTTGTAATC**CATTTGCCGAAGAGC. The italic sequences in primers were for endonuclease, and the bold sequence was to encode flag tag. A total of 50 μL PCR reaction volume (containing 5 μL 10× PCR buffer, 1.25 unit of Pfu DNA Polymerase \[Promega, USA\], 200 μM of each dNTP, 0.5 μM of each primer, and 50 ng genomic DNA) was performed by using following PCR condition: one cycle of 95°C for 1 min, 30 cycles of 95°C for 30 s, 58°C for 30 s, and 72°C for 30 s, and one extension cycle of 72°C for 5 min. Then, the PCR product was cloned into pcDNA3.1 plasmid (with flag tag in the terminal of cloned *IL6* gene) by using restriction endonuclease sites *Xho* I and *Hind* III.

2.6. Cell culture, transfection, and HCV infection {#mgg3821-sec-0012}
--------------------------------------------------

Huh7.5.1 cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; HyClone, USA) supplemented with 10% FBS and antibiotics (100 u/mL penicillin and 100 μg/mL streptomycin). After the cells were grown to 70% confluence in 6 wells plate, mixture of 2 μg IL6‐plasmid DNA and 2 μL of X‐tremeGENE HP DNA Transfection Reagent (Roche, USA) was transfected. Cells without any transfection and cells transfected with empty pcDNA3.1 vector were used as the controls. Cells were harvested at 24, 48, and 72 hr after the transfection.

HCV J6/JFH1 (muhiplieity of infection \[MOI\] = 1) was used to infect Huh7.5.1 cells with or without the *IL6* gene transfection. The infected cells were harvested at 24, 48, and 72 hr. The cells without HCV infection was used as controls.

2.7. Total RNA extraction and quantification {#mgg3821-sec-0013}
--------------------------------------------

Total RNA of control and HCV infected cells was extracted by using TRIzol Reagent (Invitrogen, USA) and reversely transcripted into complementary DNA (cDNA) by using PrimeScript™ II 1st Strand cDNA Synthesis Kit (Takara, Japan). The mRNA level of five genes were quantified by using primers (listed in Table [S3](#mgg3821-sup-0004){ref-type="supplementary-material"}), SYB® Premix ExTaqTM II kit (TaKaRa Biotechnology Co. Ltd. \[Dalian, China\]), and ABI 7500 Real‐Time PCR System (Life, USA). The single‐copy nuclear GAPDH gene was used as the reference gene.

2.8. Elisa and Western blot {#mgg3821-sec-0014}
---------------------------

The IL6 protein level in supernatant of HCV infected Huh7.5.1 cells was detected by using IL‐6 Human ELISA Kit (Invitrogen, USA) according to the manufacturer\'s instruction.

Western blot was performed to detect the protein expression level of IL6R, HNF1A, HNF4A, STAT3, pSTAT3, and ABCC2. Firstly, Huh7.5.1 cells were collected to extract total protein. Then about 20 μg protein was electrophoresed in 8--12% SDS polyacrylamide gel and was transferred to 0.45 µm polyvinylidene difluoride membrane (Life, USA) under 120 V for 2 hr. The membrane was blocked in 5% (w/v) nonfat milk for 2 hr at room temperature, then incubated with monoclonal antibodies (Abcam, China) overnight at 4°C. Finally, the membrane was incubated with secondary antibody for 1 hr and visualized by using Tanon 5500 automatic Chemiluminescent imaging analysis system (Tanon, China).

2.9. Data analysis {#mgg3821-sec-0015}
------------------

The Hardy--Weinberg equilibrium (HWE) was assessed for each SNP to identify the deviation. Pearson Chi‐square test (with Yates' correction) was used to analyze genotype and allele frequencies of SNPs between HCV‐infected persons and controls. The odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. The association between genotype of SNPs and biochemical characteristics, the RNA expressing level of each subgroups, and HCV viral load between different HCV genotypes were evaluated by using Analysis of Variance (ANOVA) or Student\'s *t* test (with welch\'s correction, two‐tailed). The homozygous genotypes less than 10 were clustered into heterozygous genotypes of SNPs for biochemical characteristics analysis. A *P*\<0.05 was considered as statistical significance. When the *P*\<0.0001, *p* \< 0.0001 was used.

3. RESULTS {#mgg3821-sec-0016}
==========

3.1. Basic and biochemical information analysis {#mgg3821-sec-0017}
-----------------------------------------------

The gender ratio (male: female) was similar between HCV‐infected group (1:2.2) and controls (1:1.9) (Table [1](#mgg3821-tbl-0001){ref-type="table"}). The biochemical characteristics GGT, ALT, AST, and HDL‐C showed significant difference between HCV‐infected individuals and controls, but ALB and TBIL were similar between them (Table [1](#mgg3821-tbl-0001){ref-type="table"}). When the HCV‐infected persons and controls were divided into male and female group, similar results with total individuals were obtained, i.e. both GGT (*p* \< 0.0001) and ALT (*p* = 0.02 and \<0.0001) were significantly higher in both male and female HCV‐infected persons than controls, and ALB and TBIL showed no difference. Interestingly, AST was higher in female HCV‐infected group than controls (*p* \< 0.0001), but it was similar between male HCV‐infected group and controls (*p* = 0.057). HDL‐C level was significantly lower in male HCV‐infected individuals than controls (*p* = 0.024), but no difference was found between female HCV‐infected individuals and controls (*p* = 0.173).

###### 

Comparison of biochemical characteristics between HCV‐infected persons and controls

  Reference range           HCV‐infected persons (*n* = 394)   Controls (*n* = 395)   *P*‐value
  ------------------------- ---------------------------------- ---------------------- -----------
  Total                                                                               
  Male                      123                                138                    0.122
  Female                    271                                257                    
  GGT (3--50 U/L)           56.63 ± 3.29                       26.80 ± 2.12           \<0.0001
  ALT (0--40 U/L)           67.27 ± 9.18                       29.29 ± 1.07           \<0.0001
  AST (0--40 U/L)           66.84 ± 9.99                       32.79 ± 0.79           0.0007
  ALB (35--51 g/L)          44.91 ± 0.22                       44.65 ± 1.11           0.818
  TBIL (3.4--17.1 µmol/L)   19.48 ± 2.59                       17.88 ± 0.61           0.549
  HDL‐C (0.7--2.0 mmol/L)   1.25 ± 0.02                        1.33 ± 0.02            0.020
  Male                                                                                
  GGT (3--50 U/L)           69.22 ± 6.64                       30.75 ± 2.79           \<0.0001
  ALT (0--40 U/L)           101.80 ± 28.50                     34.67 ± 1.82           0.020
  AST (0--40 U/L)           95.37 ± 31.57                      34.64 ± 1.52           0.057
  ALB (35--51 g/L)          44.68 ± 0.54                       45.04 ± 3.05           0.907
  TBIL (3.4--17.1 µmol/L)   23.93 ± 5.19                       22.80 ± 1.25           0.833
  HDL‐C (0.7--2.0 mmol/L)   1.18 ± 0.04                        1.31 ± 0.04            0.024
  Female                                                                              
  GGT (3--50 U/L)           50.91 ± 3.66                       24.68 ± 2.89           \<0.0001
  ALT (0--40 U/L)           51.62 ± 2.98                       26.40 ± 1.29           \<0.0001
  AST (0--40 U/L)           53.90 ± 2.22                       31.80 ± 0.89           \<0.0001
  ALB (35--51 g/L)          45.02 ± 0.21                       44.45 ± 0.46           0.253
  TBIL (3.4--17.1 µmol/L)   17.46 ± 2.94                       15.23 0.59             0.460
  HDL‐C (0.7--2.0 mmol/L)   1.29 ± 0.03                        1.34 ± 0.03            0.173

Abbreviations: ALB, albumin; ALT (or GPT), glutamic‐pyruvic transaminase; AST (or GOT), aspartate amino‐transferase; GGT, Glutamyl transpeptidase; HDL‐C, high‐density lipoprotein cholesterol; TBIL, total bilirubin.
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3.2. Association between SNPS in STAT3 signaling pathway and HCV infection {#mgg3821-sec-0018}
--------------------------------------------------------------------------

All SNPs were not deviated from HWE in both case and control populations (Table [2](#mgg3821-tbl-0002){ref-type="table"}). Genotyping and allele frequency were compared between HCV‐infected persons and controls (Table [2](#mgg3821-tbl-0002){ref-type="table"}). Genotype AA of SNP rs4075015, which belongs to the *IL6R* gene, showed significantly higher frequency in HCV‐infected persons (82/394 = 20.8%) than controls (58/395 = 14.7%) (*p* = 0.024), but other genotype and allele frequencies were similar in two cohorts. Frequencies of genotype AA and CC of rs7553796 were statistically lower (*p* = 0.0008) and higher (*p* \< 0.0001) in HCV‐infected persons than controls respectively. Similarly, allele A and C of rs7553796 showed the congruent trends in HCV‐infected individuals, i.e., HCV‐infected persons were with lower frequency of allele A (*p* \< 0.0001) and higher frequency of allele C (*p* \< 0.0001). Genotype GG of rs3212172 in the *HNF4A* gene showed higher frequency in HCV‐infected persons (29/394 = 7.4%) than controls (15/395 = 3.8%) (*p* = 0.029).

###### 

Genotype and allele frequency of genes in STAT3 signaling pathway in HCV‐infected persons and controls

  SNP                    HCV patients (*n* = 394)                                Controls (*n* = 395)   *P*‐value   OR (95% CI)[a](#mgg3821-note-0002){ref-type="fn"}
  ---------------------- ------------------------------------------------------- ---------------------- ----------- ---------------------------------------------------
  rs1524107 (*IL6*)      HWE[b](#mgg3821-note-0003){ref-type="fn"} *p* = 0.076   HWE *p* = 0.083                    
  Genotype                                                                                                           
  CC                     26                                                      22                     0.545       1.198 (0.667--2.152)
  CT                     149                                                     141                    0.537       1.096 (0.820--1.464)
  TT                     219                                                     232                    0.371       0.879 (0.663--1.166)
  Allele                                                                                                            
  C                      201                                                     185                    0.334       1.120 (0.890--1.409)
  T                      587                                                     605                                
  rs2069837 (*IL6*)      HWE *p* = 0.063                                         HWE *p* = 0.103                    
  Genotype                                                                                                          
  AA                     255                                                     265                    0.483       0.900 (0.670--1.208)
  AG                     126                                                     115                    0.382       1.145 (0.845--1.550)
  GG                     13                                                      15                     0.705       0.864 (0.406--1.842)
  Allele                                                                                                            
  A                      636                                                     645                    0.635       0.941 (0.731--1.211)
  G                      152                                                     145                                
  rs2069840 (*IL6*)      HWE *p* = 0.115                                         HWE *p* = 0.24                     
  Genotype                                                                                                          
  CC                     349                                                     362                    0.149       0.707 (0.441--1.134)
  CG                     45                                                      33                     0.149       1.414 (0.882--2.269)
  GG                     0                                                       0                      ‐           ‐
  Allele                                                                                                            
  C                      743                                                     757                    0.160       0.720 (0.454--1.141)
  G                      45                                                      33                                 
  rs2069852 (*IL6*)      HWE *p* = 0.053                                         HWE *p* = 0.054                    
  Genotype                                                                                                          
  AA                     185                                                     187                    0.913       0.985 (0.744--1.302)
  AG                     161                                                     173                    0.404       0.887 (0.668--1.176)
  GG                     48                                                      35                     0.128       1.427 (0.901--2.261)
  Allele                                                                                                            
  A                      531                                                     547                    0.429       0.918 (0.742--1.135)
  G                      257                                                     243                                
  rs4845617 (*IL6R*)     HWE *p* = 0.069                                         HWE *p* = 0.068                    
  Genotype                                                                                                          
  AA                     87                                                      87                     0.985       1.003 (0.717--1.405)
  AG                     182                                                     193                    0.453       0.899 (0.679--1.188)
  GG                     125                                                     115                    0.425       1.131 (0.835--1.533)
  Allele                                                                                                            
  A                      356                                                     367                    0.610       0.950 (0.779--1.158)
  G                      432                                                     423                                
  rs12090237 (*IL6R*)    HWE *p* = 0.306                                         HWE *p* = 0.182                    
  Genotype                                                                                                          
  AA                     1                                                       2                      0.564       0.500 (0.045--5.54)
  AG                     30                                                      31                     0.902       0.968 (0.574--1.632)
  GG                     363                                                     362                    0.802       1.067 (0.640--1.780)
  Allele                                                                                                            
  A                      32                                                      35                     0.716       0.913 (0.559--1.490)
  G                      756                                                     755                                
  rs4075015 (*IL6R*)     HWE *p* = 0.007                                         HWE *p* = 0.030                    
  Genotype                                                                                                          
  AA                     82                                                      58                     0.024       1.527 (1.055--2.211)
  AT                     160                                                     199                    0.902       1.017 (0.777--1.332)
  TT                     152                                                     138                    0.598       1.080 (0.810--1.443)
  Allele                                                                                                            
  A                      324                                                     315                    0.615       1.053 (0.861--1.287)
  T                      464                                                     475                                
  rs7553796 (*IL6R*)     HWE *p* = 0.074                                         HWE *p* = 0.004                    
  Genotype                                                                                                          
  AA                     66                                                      105                    0.0008      0.556 (0.393--0.786)
  AC                     189                                                     216                    0.059       0.764 (0.578--1.011)
  CC                     139                                                     74                     \<0.0001    2.365 (1.706--3.278)
  Allele                                                                                                            
  A                      321                                                     426                    \<0.0001    0.587 (0.481--0.717)
  C                      467                                                     364                                
  rs4845374 (*IL6R*)     HWE *p* = 0.025                                         HWE *p* = 0.090                    
  Genotype                                                                                                          
  AA                     7                                                       6                      0.776       1.173 (0.391--3.522)
  AT                     117                                                     96                     0.088       1.316 (0.960--1.804)
  TT                     270                                                     293                    0.079       0.758 (0.556--1.033)
  Allele                                                                                                            
  A                      131                                                     108                    0.102       1.259 (0.955--1.66)
  T                      657                                                     682                                
  rs4509570 (*IL6R*)     HWE *p* = 0.125                                         HWE *p* = 0.140                    
  Genotype                                                                                                          
  CC                     294                                                     315                    0.086       0.747 (0.535--1.043)
  CG                     91                                                      74                     0.132       1.303 (0.923--1.839)
  GG                     9                                                       6                      0.431       1.516 (0.534--4.300)
  Allele                                                                                                            
  C                      679                                                     704                    0.075       0.761 (0.563--1.029)
  G                      109                                                     86                                 
  rs1053023 (*STAT3*)    HWE *p* = 0.007                                         HWE *p* = 0.033                    
  Genotype                                                                                                          
  AA                     175                                                     166                    0.498       1.102 (0.832--1.461)
  AG                     187                                                     186                    0.916       1.015 (0.768--1.342)
  GG                     32                                                      43                     0.186       0.724 (0.448--1.170)
  Allele                                                                                                            
  A                      537                                                     518                    0.277       1.123 (0.911--1.386)
  G                      251                                                     272                                
  rs1053004 (*STAT3*)    HWE *p* = 0.006                                         HWE *p* = 0.025                    
  Genotype                                                                                                          
  CC                     37                                                      50                     0.143       0.715 (0.456--1.122)
  CT                     192                                                     195                    0.858       0.975 (0.737--1.289)
  TT                     165                                                     150                    0.263       1.177 (0.885--1.565)
  Allele                                                                                                            
  C                      266                                                     295                    0.137       0.855 (0.696--1.051)
  T                      522                                                     495                                
  rs4796793 (*STAT3*)    HWE *p* = 0.015                                         HWE *p* = 0.015                    
  Genotype                                                                                                          
  CC                     159                                                     147                    0.365       1.141 (0.857--1.520)
  CG                     192                                                     198                    0.695       0.946 (0.715--1.250)
  GG                     43                                                      50                     0.447       0.845 (0.548--1.304)
  Allele                                                                                                            
  C                      510                                                     492                    0.314       1.111 (0.905--1.364)
  G                      278                                                     298                                
  rs3787349 (*HNF4A*)    HWE *p* = 0.016                                         HWE *p* = 0.051                    
  Genotype                                                                                                          
  AA                     16                                                      19                     0.609       0.838 (0.424--1.654)
  AC                     151                                                     148                    0.804       1.037 (0.778--1.383)
  CC                     227                                                     228                    0.976       0.996 (0.751--1.321)
  Allele                                                                                                            
  A                      183                                                     186                    0.880       0.982 (0.778--1.240)
  C                      605                                                     604                                
  rs3212172 (*HNF4A*)    HWE *p* = 0.064                                         HWE *p* = 0.007                    
  Genotype                                                                                                          
  AA                     206                                                     226                    0.164       0.819 (0.619--1.085)
  AG                     159                                                     154                    0.695       1.059 (0.796--1.408)
  GG                     29                                                      15                     0.029       2.013 (1.062--3.816)
  Allele                                                                                                            
  A                      571                                                     606                    0.053       0.799 (0.637--1.003)
  G                      217                                                     184                                
  rs1800963 (*HNF4A*)    HWE *p* = 0.100                                         HWE *p* = 0.070                    
  Genotype                                                                                                          
  AA                     30                                                      34                     0.609       0.875 (0.524--1.460)
  AC                     187                                                     171                    0.239       1.183 (0.894--1.567)
  CC                     177                                                     190                    0.371       0.880 (0.665--1.164)
  Allele                                                                                                            
  A                      274                                                     239                    0.148       1.168 (0.946--1.441)
  C                      541                                                     551                                
  rs6073435 (*HNF4A*)    HWE *p* = 0.008                                         HWE *p* = 0.063                    
  Genotype                                                                                                          
  AA                     161                                                     168                    0.635       0.934 (0.703--1.239)
  AT                     194                                                     182                    0.374       1.135 (0.858--1.501)
  TT                     39                                                      45                     0.496       0.854 (0.543--1.345)
  Allele                                                                                                            
  A                      516                                                     518                    0.971       0.996 (0.809--1.226)
  T                      272                                                     272                                
  rs1169309 (*HNF1A*)    HWE *p* = 0.056                                         HWE *p* = 0.069                    
  Genotype                                                                                                          
  GG                     104                                                     117                    0.313       0.852 (0.624--1.163)
  GT                     198                                                     185                    0.337       1.147 (0.867--1.516)
  TT                     92                                                      93                     0.949       0.989 (0.712--1.375)
  Allele                                                                                                            
  G                      406                                                     419                    0.547       0.941 (0.772--1.147)
  T                      382                                                     371                                
  rs11065390(*HNF1A*)    HWE *p* = 0.060                                         HWE *p* = 0.071                    
  Genotype                                                                                                          
  AA                     26                                                      39                     0.094       0.645 (0.385--1.082)
  AG                     160                                                     155                    0.695       1.059 (0.796--1.408)
  GG                     208                                                     201                    0.592       1.079 (0.816--1.427)
  Allele                                                                                                            
  A                      212                                                     233                    0.253       0.880 (0.706--1.096)
  G                      576                                                     557                                
  rs41279096 (*HNF1A*)   HWE *p* = 0.789                                         HWE *p* = 0.739                    
  Genotype                                                                                                          
  AA                     0                                                       0                      1.000       ‐
  AG                     3                                                       4                      0.707       0.750 (0.167--3.373)
  GG                     391                                                     391                    0.707       1.333 (0.296--5.997)
  Allele                                                                                                            
  A                      3                                                       4                      0.707       0.751 (0.168--3.366)
  G                      785                                                     786                                
  rs1885301 (*ABCC2*)    HWE *p* = 0.055                                         HWE *p* = 0.083                    
  Genotype                                                                                                          
  AA                     13                                                      20                     0.216       0.640 (0.314--1.305)
  AG                     132                                                     117                    0.241       1.197 (0.886--1.617)
  GG                     249                                                     258                    0.535       0.912 (0.681--1.220)
  Allele                                                                                                            
  A                      158                                                     157                    0.930       1.011 (0.790--1.294)
  G                      630                                                     633                                
  rs7910642 (*ABCC2*)    HWE *p* = 0.029                                         HWE *p* = 0.043                    
  Genotype                                                                                                          
  AA                     40                                                      39                     0.896       1.031 (0.648--1.642)
  AG                     187                                                     179                    0.546       1.090 (0.824--1.442)
  GG                     167                                                     177                    0.492       0.906 (0.684--1.201)
  Allele                                                                                                            
  A                      267                                                     257                    0.569       1.063 (0.862--1.311)
  G                      521                                                     533                                
  rs2804402 (*ABCC2*)    HWE *p* = 0.062                                         HWE *p* = 0.087                    
  Genotype                                                                                                          
  AA                     252                                                     257                    0.746       0.953 (0.712--1.276)
  AG                     129                                                     118                    0.385       1.143 (0.846--1.544)
  GG                     13                                                      20                     0.216       0.640 (0.314--1.305)
  Allele                                                                                                            
  A                      633                                                     632                    0.869       1.021 (0.797--1.308)
  G                      155                                                     158                                
  rs717620 (*ABCC2*)     HWE *p* = 0.079                                         HWE *p* = 0.027                    
  Genotype                                                                                                          
  AA                     12                                                      21                     0.111       0.559 (0.271--1.153)
  AG                     121                                                     100                    0.092       1.308 (0.957--1.786)
  GG                     261                                                     274                    0.348       0.867 (0.643--1.169)
  Allele                                                                                                            
  A                      145                                                     142                    0.826       1.029 (0.797--1.329)
  G                      643                                                     648                                
  rs2273697 (*ABCC2*)    HWE *p* = 0.066                                         HWE *p* = 0.011                    
  Genotype                                                                                                          
  AA                     1                                                       0                      0.316       ‐
  AG                     64                                                      71                     0.519       0.885 (0.611--1.283)
  GG                     329                                                     324                    0.583       1.109 (0.766--1.605)
  Allele                                                                                                            
  A                      65                                                      71                     0.607       0.912 (0.641--1.296)
  G                      722                                                     719                                

When calculating odds ratio of genotype AA, genotype AB together with genotype BB of this SNP were used as reference, vice versa.

Chi‐square test for deviation from the Hardy--Weinberg equilibrium (a value of *p* \< 0.001 was regarded as a deviation from the HWE).
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3.3. Correlation between biochemical characteristics of HCV patients and genotypes of SNPs in STAT3 signaling pathway or HCV viral load {#mgg3821-sec-0019}
---------------------------------------------------------------------------------------------------------------------------------------

As listed in Table [3](#mgg3821-tbl-0003){ref-type="table"}, genotypes of two SNPs in the STAT3 signaling pathway were associated with biochemical characteristics of HCV‐infected individuals. The HDL‐C level was significantly higher in patients with genotype AG than those with GG of rs4845617 in the *IL6* gene (*p* = 0.012). The GGT level were associated with genotypes of rs1053023 in the *STAT3* gene, and its level was lower in HCV‐infected persons with genotype AA than those with genotype AG (*p* = 0.011) (Table [3](#mgg3821-tbl-0003){ref-type="table"}). Only three samples owned genotype AG of rs41279096, so we did not analyze the relationship between this SNP and biochemical characteristics of HCV patients.

###### 

Association between biochemical characteristics and SNPs of genes in *STAT3* signaling pathway in HCV‐infected persons

  Marker    rs1524107 (*IL6*)   rs2069837 (*IL6*)                                                                          
  --------- ------------------- ------------------- --------------- ------- --------------- -------------- --------------- -------
  GGT       46.92 ± 6.22        61.77 ± 6.14        54.28 ± 4.11    0.410   56.81 ± 4.07    58.35 ± 6.06   36.38 ± 9.21    0.512
  ALT       70.85 ± 13.48       53.98 ± 3.79        75.89 ± 16.23   0.525   74.53 ± 13.99   54.75 ± 4.45   46.46 ± 11.58   0.559
  AST       63.69 ± 9.24        54.56 ± 2.85        75.58 ± 17.84   0.696   73.74 ± 15.34   55.07 ± 3.31   45.69 ± 6.31    0.639
  ALB       45.39 ± 0.81        44.37 ± 0.44        45.22 ± 0.24    0.156   45.04 ± 0.25    44.57 ± 0.45   45.74 ± 1.36    0.484
  TBIL      14.10 ± 1.05        26.94 ± 6.79        15.04 ± 0.44    0.080   15.16 ± 0.43    28.68 ± 8.02   14.93 ± 1.55    0.051
  HDL‐C     1.19 ± 0.08         1.24 ± 0.04         1.26 ± 0.03     0.770   1.25 ± 0.03     1.26 ± 0.04    1.16 ± 0.12     0.758
  HCV RNA   4.90 ± 0.23         4.79 ± 0.10         4.76 ± 0.08     0.846   4.81 ± 0.08     4.74 ± 0.10    4.28 ± 0.51     0.461

  Marker   rs2069852 (*IL6*)   rs4845617 (*IL6R*)                                                                        
  -------- ------------------- -------------------- -------------- ------- -------------- --------------- -------------- -------
  GGT      56.06 ± 4.74        57.02 ± 5.23         57.48 ± 9.47   0.986   57.69 ± 8.07   57.77 ± 4.65    54.22 ± 5.51   0.884
  ALT      80.63 ± 19.15       52.95 ± 3.56         63.85 ± 8.79   0.368   58.93 ± 4.72   77.79 ± 19.42   57.77 ± 5.24   0.570
  AST      81.91 ± 21.09       51.87 ± 2.53         58.98 ± 6.10   0.358   57.75 ± 3.33   76.87 ± 21.40   58.58 ± 4.09   0.650
  ALB      45.30 ± 0.26        44.65 ± 0.38         44.30 ± 0.75   0.232   44.92 ± 0.46   44.66 ± 0.33    45.28 ± 0.38   0.472
  TBIL     15.19 ± 0.48        24.43 ± 6.08         19.39 ± 5.67   0.250   16.79 ± 0.82   21.29 ± 4.63    18.70 ± 4.59   0.783
  HDL‐C    1.28 ± 0.04         1.25 ± 0.04          1.18 ± 0.06    0.416   1.28 ± 0.05    1.30 ± 0.04     1.17 ± 0.04    0.045
  HCV      4.77 ± 0.09         4.83 ± 0.10          4.63 ± 0.18    0.588   4.71 ± 0.11    4.90 ± 0.10     4.66 ± 0.11    0.208

  Marker   rs4075015 (*IL6R*)   rs7553796 (*IL6R*)                                                                         
  -------- -------------------- -------------------- --------------- ------- -------------- -------------- --------------- -------
  GGT      58.70 ± 7.10         53.80 ± 4.48         58.49 ± 5.99    0.777   44.97 ± 7.11   56.41 ± 4.19   62.45 ± 6.53    0.200
  ALT      57.77 ± 6.26         58.12 ± 4.32         82.04 ± 23.12   0.445   46.11 ± 4.90   62.07 ± 4.32   84.40 ± 25.23   0.322
  AST      59.70 ± 5.50         53.31 ± 2.52         84.94 ± 25.58   0.348   48.70 ± 3.38   59.15 ± 3.24   85.92 ± 27.92   0.347
  ALB      45.01 ± 0.50         45.19 ± 0.33         44.56 ± 0.37    0.435   45.06 ± 0.51   45.05 ± 0.33   44.65 ± 0.36    0.681
  TBIL     14.30 ± 0.84         18.98 ± 3.63         22.79 ± 5.51    0.480   22.12 ± 8.66   19.66 ± 4.24   17.97 ± 2.03    0.863
  HDL‐C    1.18 ± 0.05          1.25 ± 0.04          1.29 ± 0.04     0.266   1.17 ± 0.05    1.25 ± 0.03    1.30 ± 0.05     0.215
  HCV      4.65 ± 0.12          4.90 ± 0.10          4.73 ± 0.10     0.259   4.66 ± 0.15    4.85 ± 0.09    4.72 ± 0.10     0.456

  Marker   rs1053023 (*STAT3*)   rs1053004 (*STAT3*)                                                                         
  -------- --------------------- --------------------- --------------- ------- --------------- -------------- -------------- -------
  GGT      47.09 ± 3.89          64.14 ± 5.36          64.88 ± 13.53   0.034   64.81 ± 12.61   61.69 ± 5.15   48.90 ± 4.16   0.132
  ALT      54.16 ± 3.17          61.68 ± 4.00          63.71 ± 11.63   0.345   59.64 ± 10.28   60.63 ± 4.03   55.75 ± 3.73   0.683
  AST      57.38 ± 3.42          56.52 ± 2.40          58.39 ± 7.54    0.960   56.94 ± 6.69    57.89 ± 2.86   56.10 ± 3.06   0.913
  ALB      45.31 ± 0.29          44.64 ± 0.36          44.34 ± 0.76    0.259   44.22 ± 0.67    44.66 ± 0.36   45.36 ± 0.28   0.190
  TBIL     19.18 ± 4.55          17.14 ± 1.59          34.74 ± 17.80   0.201   31.60 ± 15.42   17.11 ± 1.54   19.51 ± 4.83   0.293
  HDL‐C    1.28 ± 0.03           1.24 ± 0.04           1.19 ± 0.11     0.581   1.18 ± 0.09     1.26 ± 0.04    1.26 ± 0.04    0.597
  HCV      4.79 ± 0.10           4.74 ± 0.09           4.93 ± 0.20     0.703   4.90 ± 0.20     4.76 ± 0.09    4.77 ± 0.10    0.821

  Marker   rs4796793 (*STAT3*)   rs3787349 (*HNF4A*)                                                                         
  -------- --------------------- --------------------- --------------- ------- -------------- --------------- -------------- -------
  GGT      48.86 ± 4.00          59.78 ± 5.25          71.28 ± 11.45   0.087   34.25 ± 5.98   54.53 ± 4.71    59.60 ± 4.73   0.286
  ALT      55.58 ± 3.97          58.87 ± 3.91          67.79 ± 9.20    0.414   49.25 ± 9.07   81.99 ± 23.29   58.76 ± 3.67   0.442
  AST      57.66 ± 3.67          55.01 ± 2.36          64.05 ± 6.11    0.393   52.31 ± 6.71   84.27 ± 25.79   56.27 ± 2.45   0.389
  ALB      45.25 ± 0.29          44.81 ± 0.34          44.11 ± 0.76    0.287   45.12 ± 0.60   44.86 ± 0.38    44.93 ± 0.28   0.968
  TBIL     14.54 ± 0.47          20.78 ± 4.37          31.88 ± 13.37   0.130   14.23 ± 1.04   15.74 ± 0.68    14.75 ± 0.43   0.372
  HDL‐C    1.30 ± 0.04           1.21 ± 0.03           1.27 ± 0.09     0.246   1.26 ± 0.15    1.23 ± 0.04     1.27 ± 0.03    0.829
  HCV      4.82 ± 0.10           4.74 ± 0.09           4.81 ± 0.19     0.817   4.99 ± 0.35    4.89 ± 0.10     4.68 ± 0.08    0.204

  Marker   rs3212172 (*HNF4A*)   rs1800963 (*HNF4A*)                                                                         
  -------- --------------------- --------------------- --------------- ------- -------------- --------------- -------------- -------
  GGT      58.81 ± 4.83          52.47 ± 4.52          63.90 ± 14.39   0.540   44.57 ± 7.82   59.40 ± 4.82    55.74 ± 5.08   0.498
  ALT      57.40 ± 3.31          78.82 ± 22.19         74.10 ± 14.94   0.523   51.77 ± 8.36   77.88 ± 18.93   58.70 ± 3.98   0.539
  AST      58.80 ± 2.79          77.58 ± 24.47         65.10 ± 8.45    0.669   48.93 ± 4.32   78.41 ± 20.85   57.66 ± 3.01   0.534
  ALB      44.99 ± 0.25          44.88 ± 0.40          44.50 ± 0.93    0.846   45.01 ± 0.92   44.91 ± 0.31    44.90 ± 0.33   0.992
  TBIL     21.43 ± 4.74          17.73 ± 1.91          15.19 ± 1.11    0.712   14.11 ± 1.00   20.24 ± 4.27    19.58 ± 3.61   0.833
  HDL‐C    1.29 ± 0.03           1.22 ± 0.04           1.18 ± 0.07     0.325   1.21 ± 0.08    1.26 ± 0.04     1.25 ± 0.04    0.866
  HCV      4.71 ± 0.08           4.90 ± 0.10           4.64 ± 0.23     0.279   4.52 ± 0.27    4.85 ± 0.09     4.74 ± 0.09    0.387

  Marker   rs6073435 (*HNF4A*)   rs1169309 (*HNF1A*)                                                                        
  -------- --------------------- --------------------- -------------- ------- -------------- --------------- -------------- -------
  GGT      56.17 ± 4.92          58.03 ± 5.07          51.51 ± 7.61   0.845   51.21 ± 4.59   64.35 ± 5.47    46.12 ± 5.51   0.052
  ALT      80.98 ± 21.92         58.41 ± 3.76          54.77 ± 8.07   0.461   62.81 ± 6.05   76.69 ± 17.86   52.07 ± 4.63   0.541
  AST      80.50 ± 24.14         58.16 ± 3.09          53.67 ± 5.39   0.522   58.67 ± 3.95   77.88 ± 19.70   52.33 ± 3.48   0.528
  ALB      45.14 ± 0.29          44.80 ± 0.35          44.49 ± 0.74   0.631   44.66 ± 0.49   44.89 ± 0.31    45.25 ± 0.39   0.634
  TBIL     23.71 ± 6.06          16.74 ± 1.48          15.61 ± 2.49   0.396   21.57 ± 5.51   16.40 ± 1.46    23.72 ± 8.67   0.473
  HDL‐C    1.26 ± 0.04           1.23 ± 0.03           1.33 ± 0.09    0.523   1.24 ± 0.05    1.26 ± 0.03     1.25 ± 0.05    0.945
  HCV      4.82 ± 0.09           4.78 ± 0.09           4.54 ± 0.22    0.501   4.73 ± 0.11    4.81 ± 0.09     4.76 ± 0.13    0.878

  Marker   rs11065390 (*HNF1A*)   rs1885301 (*ABCC2*)                                                                          
  -------- ---------------------- --------------------- --------------- ------- --------------- --------------- -------------- -------
  GGT      47.00 ± 6.55           60.44 ± 5.44          54.89 ± 4.53    0.533   69.54 ± 17.59   62.34 ± 6.03    52.92 ± 3.99   0.313
  ALT      45.65 ± 6.27           63.64 ± 4.58          72.77 ± 17.02   0.735   82.31 ± 21.61   91.36 ± 26.62   53.72 ± 3.13   0.152
  AST      51.00 ± 5.67           59.35 ± 3.04          74.59 ± 18.78   0.702   64.54 ± 9.45    90.33 ± 29.41   54.51 ± 2.48   0.245
  ALB      43.80 ± 0.92           44.88 ± 0.34          45.08 ± 0.30    0.374   47.94 ± 0.77    44.64 ± 0.35    44.90 ± 0.29   0.034
  TBIL     36.51 ± 21.89          16.53 ± 1.76          19.62 ± 3.86    0.185   14.65 ± 1.44    25.79 ± 7.38    16.38 ± 1.21   0.224
  HDL‐C    1.11 ± 0.08            1.27 ± 0.04           1.26 ± 0.03     0.312   1.23 ± 0.16     1.22 ± 0.04     1.27 ± 0.03    0.556
  HCV      4.54 ± 0.31            4.93 ± 0.09           4.68 ± 0.08     0.091   4.48 ± 0.26     4.90 ± 0.10     4.73 ± 0.08    0.274

  Marker   rs7910642 (*ABCC2*)   rs2804402 (*ABCC2*)                                                                          
  -------- --------------------- --------------------- --------------- ------- -------------- --------------- --------------- -------
  GGT      54.40 ± 9.42          57.93 ± 5.19          55.70 ± 4.64    0.926   52.80 ± 3.95   62.81 ± 6.16    69.54 ± 17.59   0.282
  ALT      60.78 ± 8.95          56.92 ± 3.96          80.43 ± 21.09   0.468   54.12 ± 3.11   91.45 ± 27.23   82.31 ± 21.61   0.160
  AST      58.43 ± 5.93          55.89 ± 3.12          81.12 ± 23.27   0.472   54.65 ± 2.46   90.90 ± 30.09   64.54 ± 9.45    0.241
  ALB      45.44 ± 0.59          44.68 ± 0.32          45.04 ± 0.35    0.541   44.92 ± 0.29   44.58 ± 0.35    47.94 ± 0.77    0.030
  TBIL     14.99 ± 0.76          19.29 ± 4.27          20.76 ± 3.83    0.816   19.54 ± 3.36   19.84 ± 4.46    14.65 ± 1.44    0.941
  HDL‐C    1.32 ± 0.07           1.25 ± 0.03           1.25 ± 0.04     0.639   1.28 ± 0.03    1.21 ± 0.04     1.22 ± 0.16     0.495
  HCV      4.63 ± 0.20           4.82 ± 0.09           4.76 ± 0.09     0.653   4.73 ± 0.08    4.91 ± 0.10     4.48 ± 0.26     0.239

  Marker   rs717620 (*ABCC2*)                                  
  -------- -------------------- --------------- -------------- -------
  GGT      66.50 ± 18.84        64.18 ± 6.52    52.67 ± 3.83   0.240
  ALT      83.33 ± 23.47        95.13 ± 29.01   53.62 ± 3.00   0.111
  AST      65.58 ± 10.21        94.13 ± 32.07   54.25 ± 2.38   0.188
  ALB      47.52 ± 0.70         44.62 ± 0.37    44.93 ± 0.28   0.090
  TBIL     14.95 ± 1.53         20.16 ± 4.75    19.37 ± 3.24   0.944
  HDL‐C    1.22 ± 0.18          1.21 ± 0.04     1.28 ± 0.03    0.458
  HCV      4.42 ± 0.28          4.89 ± 0.11     4.74 ± 0.08    0.278

  Marker   rs2069840 (*IL6*)   rs12090237 (*IL6R*)   rs4845374 (*IL6R*)                                                                          
  -------- ------------------- --------------------- -------------------- --------------- -------------- -------- --------------- -------------- -------
  GGT      56.03 ± 3.44        61.24 ± 10.94         0.614                57.84 ± 9.97    56.52 ± 3.47   0.914    62.07 ± 6.26    54.13 ± 3.84   0.262
  ALT      67.44 ± 10.29       66.00 ± 9.57          0.960                174.0 ± 111.9   58.16 ± 2.81   0.0006   84.64 ± 28.25   59.30 ± 3.37   0.200
  AST      67.45 ± 11.25       62.16 ± 6.56          0.867                183.9 ± 124.6   56.84 ± 2.07   0.0006   87.15 ± 31.33   57.52 ± 2.39   0.169
  ALB      45.07 ± 0.23        43.70 ± 0.75          0.048                44.43 ± 0.92    44.95 ± 0.23   0.522    44.84 ± 0.38    44.95 ± 0.27   0.818
  TBIL     20.15 ± 2.92        14.26 ± 1.23          0.470                18.41 ± 2.21    19.57 ± 2.81   0.905    24.02 ± 6.75    17.39 ± 2.17   0.235
  HDL‐C    1.27 ± 0.03         1.16 ± 0.06           0.192                1.32 ± 0.11     1.25 ± 0.03    0.463    1.23 ± 0.04     1.27 ± 0.03    0.505
  HCV      4.74 ± 0.06         5.02 ± 0.18           0.136                5.11 ± 0.24     4.75 ± 0.06    0.138    4.73 ± 0.12     4.80 ± 0.07    0.572

  Marker   rs4509570 (*IL6R*)   rs2273697 (*ABCC2*)                                          
  -------- -------------------- --------------------- ------- --------------- -------------- -------
  GGT      58.57 ± 3.95         50.90 ± 5.72          0.310   55.40 ± 7.64    56.87 ± 3.64   0.868
  ALT      71.42 ± 12.20        55.08 ± 4.52          0.439   107.6 ± 53.73   59.32 ± 2.91   0.051
  AST      70.83 ± 13.34        55.11 ± 3.34          0.494   113.7 ± 59.64   57.59 ± 2.14   0.037
  ALB      45.03 ± 0.24         44.56 ± 0.51          0.348   45.14 ± 0.49    44.87 ± 0.25   0.648
  TBIL     18.63 ± 2.86         21.97 ± 5.80          0.576   16.99 ± 1.71    19.97 ± 3.09   0.670
  HDL‐C    1.27 ± 0.03          1.20 ± 0.04           0.230   1.35 ± 0.07     1.24 ± 0.03    0.088
  HCV      4.78 ± 0.07          4.78 ± 0.12           0.990   4.83 ± 0.15     4.77 ± 0.07    0.717

All biochemical characteristic were Mean ± SE.

Abbreviations: ALB, albumin; ALT (or GPT), glutamic‐pyruvic transaminase; AST (or GOT), aspartate amino‐transferase; GGT, Glutamyl transpeptidase; HDL‐C, high‐density lipoprotein cholesterol; TBIL, total bilirubin

John Wiley & Sons, Ltd

HCV RNA of a total of 266 HCV‐infected persons were extracted, but HCV genotypes were successfully determined in 105 patients due to long amplicon. The results showed that 16, 19, 5, 58, 1, and 6 patients infected by HCV with genotype 1B, 2A, 3A, 3B, 6A, and 6N, respectively. Genotype 3B was the frequent genotype (58/105, 55.24%) in this study, and this distribution was similar with the reported study in Yunnan (Li et al., [2017](#mgg3821-bib-0019){ref-type="ref"}). HCV viral load was quantified in all 266 HCV‐infected persons. Because only one individual belonged genotype 6A, this genotype was excluded in further biochemical characteristics analysis. The ALT (*p* = 0.002), AST (*p* = 0.0001), ALB level (*p* = 0.047), and HCV viral load (*p* = 0.011) showed significant difference among HCV subgroups (Table [4](#mgg3821-tbl-0004){ref-type="table"}). ALT (83.53 ± 7.34) and AST (80.40 ± 6.56) expressed higher level in HCV‐infected persons with genotype 3B. ALB level (39.41 ± 1.85) and HCV viral load (5.19 ± 0.42) was much lower in HCV‐infected persons with genotype 2A.

###### 

Analysis of biochemical features and viral load among patients with various HCV genotypes

               1B (*n* = 16)   2A (*n* = 19)   3A (*n* = 5)    3B (*n* = 58)   6N (*n* = 6)    *P*‐value
  ------------ --------------- --------------- --------------- --------------- --------------- -----------
  GGT          77.06 ± 25.90   45.21 ± 15.23   87.20 ± 26.97   70.95 ± 7.89    47.00 ± 18.19   0.503
  ALT          48.38 ± 10.69   29.39 ± 5.83    72.60 ± 22.69   83.53 ± 7.34    52.50 ± 29.23   0.002
  AST          47.25 ± 5.50    34.78 ± 4.75    49.40 ± 4.37    80.40 ± 6.56    34.67 ± 9.17    0.0001
  ALB          44.00 ± 1.12    39.41 ± 1.85    42.78 ± 3.37    43.76 ± 0.59    43.65 ± 1.28    0.047
  TBIL         12.66 ± 1.58    21.80 ± 5.92    14.98 ± 4.05    16.22 ± 1.01    13.22 ± 2.04    0.283
  HDL‐C        1.25 ± 0.08     0.96 ± 0.13     1.08 ± 0.10     1.19 ± 0.06     0.96 ± 0.14     0.194
  Viral load   5.89 ± 0.17     5.19 ± 0.42     5.63 ± 0.28     5.33 ± 0.07     6.16 ± 0.40     0.011

Abbreviations: ALB, albumin; ALT (or GPT), glutamic‐pyruvic transaminase; AST (or GOT), aspartate amino‐transferase; GGT, Glutamyl transpeptidase; HDL‐C, high‐density lipoprotein cholesterol; TBIL, total bilirubin.

John Wiley & Sons, Ltd

3.4. Variation of mRNA and protein expression level after HCV infection with or without IL6 transfection {#mgg3821-sec-0020}
--------------------------------------------------------------------------------------------------------

All above results suggested genetic polymorphisms in the STAT3 signaling pathway might be associated with HCV infection, so functional assays were further performed to identify the role of this pathway. We studied mRNA and protein expression of six genes in STAT3 signaling pathway, after Huh7.5.1 cells were infected by HCV with or without transfection of the *IL6* gene. We identified that IL6 protein expression gradually increased in HCV‐infected cells (Figure [1](#mgg3821-fig-0001){ref-type="fig"}), but no statistical difference was found. HCV viral load time‐dependently increased from 24 to 72 hr after HCV infection (Figure [2](#mgg3821-fig-0002){ref-type="fig"}a). The mRNA level of the *HNF1A* and *STAT3* genes showed time‐dependent increasing in HCV‐infected cells (Figure [2](#mgg3821-fig-0002){ref-type="fig"}b). While mRNA level of the *IL6R* and *ABCC2* genes were highest in 48 hr (Figure [2](#mgg3821-fig-0002){ref-type="fig"}b). The *HNF4A* gene showed no statistical difference in mRNA level. However, mRNA expression was different from proteins. All six proteins (IL6R, HNF4A, HNF4A, STAT3, pSTAT3, and MRP) in this pathway seemed high expression at 72 hr after HCV infection (Figure [2](#mgg3821-fig-0002){ref-type="fig"}c).

![IL6 expression level in HCV infected cells with or without IL6 transfection. The IL6 protein level was detected in cells infected by HCV and cells transfected with the *IL6* gene and infected by HCV](MGG3-7-e821-g001){#mgg3821-fig-0001}

![HCV viral load and expression level of genes in STAT3 signaling pathway after HCV infection. (a) time‐dependent increasing HCV RNA level; (b) mRNA expression level variation of the IL6R, HNF1A, HNF4A, STAT3, and ABCC2 genes at 24, 48, and 72 hr after the Huh7.5.1 cells were infected with HCV; (c) expression level of the IL6R, HNF1A, HNF4A, STAT3, pSTAT3, and ABCC2 proteins at 24, 48, and 72 hr after the Huh7.5.1 cells were infected with HCV. NC means normal controls, i.e., the cells without HCV infection; mock means the negative controls, i.e., the cells were infected with PBS](MGG3-7-e821-g002){#mgg3821-fig-0002}

In order to detect whether STAT3 signaling pathway could influence HCV proliferation in vitro, the IL6 gene was overexpressed in Huh7.5.1 cells. After analyzing RNA and protein expression in IL6‐transfected and HCV‐infected cells, IL6 protein level significantly increased (Figure [1](#mgg3821-fig-0001){ref-type="fig"}). The *P* value was 0.0001, 0.002, and 0.0008, respectively, when comparing expressing level at 24 hr with control, expressing level at 48 hr with that at 24 hr, and expressing level at 48 hr with that at 72 hr. Meanwhile, the expression of flag suggested that the IL6 gene was successfully transfected into cells. HCV viral load significantly decreased at 24 hr (*p* \< 0.0001) and increased at 72 hr (*p* \< 0.0001) after infection (Figure [3](#mgg3821-fig-0003){ref-type="fig"}a). Similar to results of HCV infection, the mRNA level of the *IL6R*, *HNF1A*, and *STAT3* genes were significantly increased, but the mRNA level did not change in the *HNF4A* and *ABCC2* genes (Figure [3](#mgg3821-fig-0003){ref-type="fig"}b). When we analyzed the proteins expression of the STAT3 signaling pathway, IL6R, HNF1A, HNF4A, 2STAT3, pSTAT3, and ABCC2 proteins time‐dependently increased (Figure [3](#mgg3821-fig-0003){ref-type="fig"}c). These results identified that the transfected IL6 gene could effectively inhibit HCV proliferation by upregulating proteins expression level in STAT3 signaling pathway.

![HCV viral load and expression level of genes in STAT3 signaling pathway after IL6 transfection and HCV infection. (a) HCV RNA level, the RNA level decreased at 24 hr after HCV infection in Huh7.5.1 cells transfected with IL6 gene; (b) mRNA expressing level variation of the IL6R, HNF1A, HNF4A, STAT3, and ABCC2 genes at 24, 48, and 72 hr after the HCV infection in Huh7.5.1 cells transfected with IL6 gene; (c) expressing level of the IL6R, HNF1A, HNF4A, STAT3, pSTAT3, and ABCC2 proteins at 24, 48, and 72 hr after HCV infection in Huh7.5.1 cells transfected with IL6 gene. NC means normal controls, i.e., the cells without HCV infection; HCV NC means cells infected by HCV; plasmid NC means cells transfected with the IL6 gene and infected by HCV](MGG3-7-e821-g003){#mgg3821-fig-0003}

4. DISCUSSION {#mgg3821-sec-0021}
=============

HCV infection was one of the seriously infectious hepatitis disease, so to further study and understand the mechanisms of HCV‐infection was needed. In this study, we collected several biochemical features of HCV‐infected persons to investigate whether there was the relationship between genetic polymorphisms in STAT3 signaling pathway and biochemical features. GGT, ALT, and AST levels in HCV patients were significantly higher than those in controls, and HDL‐C level in HCV patients was lower than that in controls (Table[1](#mgg3821-tbl-0001){ref-type="table"}). However, AST and HDL‐C levels were similar in male and female cohorts, respectively. These results indicated that different results of AST and HDL‐C level might be caused by gender difference, so more samples should be further studied. In our previous study, ALT/AST ratio and TBIL level were associated with SNPs in the *IFNλ* genes (Zhang et al., [2014](#mgg3821-bib-0037){ref-type="ref"}), and GGT, AST, and TBIL levels were related with SNPs in the *NPC1L1* gene of the HCV‐infected persons (Zhang et al., [2016](#mgg3821-bib-0038){ref-type="ref"}). In addition, SNPs in the *CD81*, SCARB1, and *CLDN1* genes, which were essential for HCV particle entry, were found to correlate with metabolic features of HCV patients (Nafari et al., [2018](#mgg3821-bib-0022){ref-type="ref"}; Sun, Jin, & Kang, [2015](#mgg3821-bib-0031){ref-type="ref"}). Similar to this study, ALT, AST, and HDL‐C level could be influenced by genotypes of SNP in these genes (Nafari et al., [2018](#mgg3821-bib-0022){ref-type="ref"}; Sun et al., [2015](#mgg3821-bib-0031){ref-type="ref"}). Together with our and others previous results, we suggested that biochemical features of HCV‐infected persons were associated with genetic polymorphisms of patients.

The proteins in STAT3 signaling pathway played important roles in HCV infection or HCC (Ji et al., [2018](#mgg3821-bib-0016){ref-type="ref"}; Kao et al., [2017](#mgg3821-bib-0017){ref-type="ref"}; Qadri et al., [2006](#mgg3821-bib-0025){ref-type="ref"}). HCV infection could lead to increasing of HNF1A and HNF4A proteins, which caused upregulation of ABCC2 (Qadri et al., [2006](#mgg3821-bib-0025){ref-type="ref"}). Aboulnasr *et al.* identified IFNλ could inhibit HCV replication through suppression miR122‐ STAT3‐ HNF4A feedback loop (Aboulnasr et al., [2015](#mgg3821-bib-0001){ref-type="ref"}). However, in Vallianou\'s study, HCV infection might lead to HCC through decreasing of HNF4A, HNF1A, and ABCC2 (Vallianou, Dafou, Vassilaki, Mavromara, & Hadzopoulou‐Cladaras, [2016](#mgg3821-bib-0036){ref-type="ref"}). This result differed from the study by Qadri *et al*. The miR‐125b has been reported to be an inhibitor for HCC (Kim et al., [2013](#mgg3821-bib-0018){ref-type="ref"}), while IL6/STAT3 pathway could upregulate the expression of miR‐125b in HCV infected cells (Dai et al., [2018](#mgg3821-bib-0009){ref-type="ref"}), which means that STAT3 pathway could prevent HCV infected cells from HCC. Although the results existed discrepancy in these studies, it suggested HCV infection and progression closely related with IL6/STAT3 signaling pathway. However, all these studies focused on the functional role of STAT3 pathway, and whether genetic SNPs of STAT3 pathway was associated with HCV infection was unknown. Thus, the precise role of STAT3 pathway needs further study.

Many host genetic factors have been studied to explore the susceptibility of HCV infection in different populations (Steba et al., [2018](#mgg3821-bib-0030){ref-type="ref"}; Swiatek‐Koscielna et al., [2017](#mgg3821-bib-0032){ref-type="ref"}; Zhang et al., [2014](#mgg3821-bib-0037){ref-type="ref"}, [2016](#mgg3821-bib-0038){ref-type="ref"}), but it seemed that no high coincident result in these cohorts. IL6 was the most reported gene to be associated with HCV infected persons or HCC patients caused by chronic HCV infection. SNP rs1800795 was associated with treatment of HCV patients infected by drug injection in Croatian (Bogdanovic et al., [2016](#mgg3821-bib-0006){ref-type="ref"}). Moreover, the polymorphisms of the *IL6* gene were reported to influence the histologic progression and clinical outcomes of HCV patients (Falleti et al., [2010](#mgg3821-bib-0011){ref-type="ref"}; Sghaier et al., [2017](#mgg3821-bib-0026){ref-type="ref"}). Although daclatasvir plasma concentration significantly increased in the HCV infected patients with genotype CC of SNP rs1884613 in the *HNF4A* gene (Cusato et al., [2017](#mgg3821-bib-0007){ref-type="ref"}), the relationship between SNPs in this gene and HCV infection was not studied. The genetic role of other four genes in STAT3 signaling pathway was not reported. We firstly identified that SNPs in the STAT3 signaling pathway were associated with HCV infection (*IL6R* and *HNF4A* genes) or biochemical features of HCV patients (*IL6* and *STAT3* genes) in Yunnan population. Thus, our results suggested that the genetic polymorphisms of the genes in STAT3 signaling pathway exerted important roles in HCV infection, biochemical features of patients, and even disease progression.

The treatment effect was different in patients with various HCV genotypes (Atsukawa et al., [2018](#mgg3821-bib-0003){ref-type="ref"}; Di Biagio, Taramasso, & Cenderello, [2018](#mgg3821-bib-0010){ref-type="ref"}; Otsuka et al., [2017](#mgg3821-bib-0024){ref-type="ref"}). Similarly, we identified that the ALT, AST, ALB, and viral load level showed significant difference among the HCV patients with subtypes (Table [4](#mgg3821-tbl-0004){ref-type="table"}). This indicated that HCV genotypes might influence the biochemical features and treatment of HCV patients. High ALB level in the patients with HCV genotype 2A might be due to the lower HCV viral load in these patients.

High IL6 level linked with phosphorylated STAT3 level, poor liver function, variceal severity, and patients\' mortality in cirrhotic patients caused by HBV‐ and HCV‐infection (Kao et al., [2017](#mgg3821-bib-0017){ref-type="ref"}). Similarly, Nakagawa *et al.* identified that high serum level of IL6 was associated with liver‐related mortality in chronic HCV patients (Nakagawa et al., [2015](#mgg3821-bib-0023){ref-type="ref"}). Moreover, plasma level of IL6 could be a predicted index of interferon‐α plus ribavirin therapy in HIV/HCV co‐infected patients (Guzman‐Fulgencio et al., [2012](#mgg3821-bib-0013){ref-type="ref"}). In this study, we identified that HCV RNA level significantly increased at 24, 48, and 72 hr after HCV infection, but it significantly decreased after 24 hr transfection of the IL6 gene and HCV infection than in control cells. This meant that high expression of IL6 could dampen HCV reproduction (Figure [3](#mgg3821-fig-0003){ref-type="fig"}a). Similar to Qadri\'s results (Qadri et al., [2006](#mgg3821-bib-0025){ref-type="ref"}), we found that mRNA and proteins expression of IL6R, HNF1A, STAT3, and ABCC2 (ABCC2) significantly increased in cells infected by HCV with or without IL6 transfection, but HNF4A showed no statistical difference. Interestingly, HNF1A, HNF4A, and ABCC2 were downregulated by HCV infection, but IL6R and STAT3 increased in another research (Vallianou et al., [2016](#mgg3821-bib-0036){ref-type="ref"}). It has been reported that downregulation of STAT3 could suppress hepatocytes proliferation and enhance the anti‐apoptotic ability of inflammatory hepatocytes (Starkel, Saeger, Leclercq, & Horsmans, [2007](#mgg3821-bib-0029){ref-type="ref"}). Thus, we suggested that upregulated STAT3 might slow down the progression of hepatocytes caused by HCV infection. However, the function of the STAT3 signaling pathway in HCV infection needed further verification in animal model.

We firstly identified that genetic polymorphisms of the genes in STAT3 signaling pathway were associated with HCV infection and biochemical features of HCV patients in Yunnan population. In summary, the genes in the STAT3 signaling pathway played important roles in HCV infection through both genetic and functional aspects.
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